• Taking on ovarian cancer in the peloton and the lab

Dr Jim Coward at the 2015 Noosa Cycle
Each year 1300 Australian women will receive the heartbreaking news that they have been diagnosed with ovarian cancer.* Tragically two-thirds of these women, our friends, mothers, sisters and daughters, will eventually die from the disease. 

That’s a figure that hasn’t changed in 15 years. 

With your support Smiling for Smiddy is helping to raise essential funds for research into ovarian cancer diagnosis and treatment, to decrease the number of women being diagnosed and raise survival rates.

This research is carried out by the Mater Ovarian Cancer Research Collaborative (MOCRC) team, who have a clear vision for improving outcomes for ovarian cancer patients.  

And the MOCRC team has its very own Smiddy rider, Dr Jim Coward (pictured at right), who completed the 2015 Noosa Smiddy Cycle in April this year.

Dr Coward and the MOCRC research team have been able to develop and test ways of reducing the size of cancerous tumours which will form the basis for clinical trials–which they hope to start next year.

“Thanks to the support of people like you, our research team has been making valuable headway in the study of ovarian cancer. We have found a way to inhibit a particular protein’s ability to encourage ovarian cancer cells to spread throughout the body,” said Dr Coward.

It’s inspiring to know there are researchers like Dr Coward, in the Smiddy peloton and at the Mater Research labs, fighting alongside us to reduce the devastating impact of ovarian cancer.


*Statistics sourced from Australian Institute of Health and Welfare.






The Mater Foundation is registered as a charity with the Australian Charities and Not-for-profits Commission ABN 96723184640.